Advertisement
Research Article Free access | 10.1172/JCI111858
Find articles by Tsang, K. in: JCI | PubMed | Google Scholar
Find articles by Fudenberg, H. in: JCI | PubMed | Google Scholar
Find articles by Galbraith, G. in: JCI | PubMed | Google Scholar
Find articles by Donnelly, R. in: JCI | PubMed | Google Scholar
Find articles by Bishop, L. in: JCI | PubMed | Google Scholar
Find articles by Koopmann, W. in: JCI | PubMed | Google Scholar
Published May 1, 1985 - More info
The in vitro effects of isoprinosine (ISO) on interleukin-2 (IL-2) production, the expression of Tac antigen (IL-2 receptor) on lymphocytes, and the ability of Leu 3(+) cells to absorb interleukin-1 (IL-1) were investigated in 10 patients with acquired immune deficiency syndrome (AIDS). In 9 of the 10 patients, production of IL-2 from mononuclear cells and Leu 3(+) cells was depressed; expression of Tac antigen on mononuclear cells and Leu 2(+) cells was found to be depressed in 9 of 10 patients. The ability of the Leu 3(+) lymphocytes to absorb IL-1 was depressed in all (four of four) patients studied. After ISO treatment, IL-2 production, Tac antigen expression and IL-1 absorption were restored to normal or near normal levels in most of the patients. These results suggest that ISO has an immunostimulating capacity in AIDS patients and that the potential of ISO in immune response restoration in AIDS patients deserves critical consideration.